Literature DB >> 14578215

Leukotriene D4 activates alveolar epithelial Na,K-ATPase and increases alveolar fluid clearance.

Daniel E Sloniewsky1, Karen M Ridge, Yochai Adir, Francine P Fries, Arturo Briva, Jacob I Sznajder, Peter H S Sporn.   

Abstract

Cysteinyl leukotrienes are increased during acute lung injury in animals and humans. In this study, we determined the effect of leukotriene D4 (LTD4) on the function of Na,K-ATPase in alveolar epithelial cells and on alveolar fluid clearance in rat lungs. LTD4 (1 x 10(-7) M) increased Na,K-ATPase activity at 1 and 5 minutes by 14% (p < 0.05) and 31% (p < 0.001), respectively, in A549 alveolar epithelial cells. This was accompanied by recruitment of Na,K-ATPase alpha1 subunits from intracellular compartment(s) to the basolateral plasma membrane. LTD4-induced alpha1 Na,K-ATPase membrane translocation was blocked by the dual cysteinyl LT1 (cysLT1)/ cysteinyl LT3 (cysLT3) receptor antagonist BAY-u9773, but not by the cysLT1 antagonist MK571, implicating the cysLT3 receptor. Expression of mRNA for cysLT2, but not cysLT1, was confirmed in A549 cells and rat alveolar type 2 cells by reverse transcriptase-polymerase chain reaction. Finally, compared with control, LTD4 (1 x 10(-11) M) increased alveolar fluid clearance by 41% (p < 0.001) in isolated, perfused rat lungs; this was also blocked by BAY-u9773 but not MK571. By activating alveolar epithelial Na,K-ATPase and increasing alveolar fluid reabsorption, cysteinyl leukotrienes may, in part, have a beneficial role in the acute respiratory distress syndrome.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14578215     DOI: 10.1164/rccm.200304-472OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  7 in total

1.  Leukotrienes in acute lung injury: a potential therapeutic target?

Authors:  James A Frank; Michael A Matthay
Journal:  Am J Respir Crit Care Med       Date:  2005-08-01       Impact factor: 21.405

Review 2.  Cytokine-Ion Channel Interactions in Pulmonary Inflammation.

Authors:  Jürg Hamacher; Yalda Hadizamani; Michèle Borgmann; Markus Mohaupt; Daniela Narcissa Männel; Ueli Moehrlen; Rudolf Lucas; Uz Stammberger
Journal:  Front Immunol       Date:  2018-01-04       Impact factor: 7.561

3.  Type 2 Cysteinyl Leukotriene Receptors Drive IL-33-Dependent Type 2 Immunopathology and Aspirin Sensitivity.

Authors:  Tao Liu; Nora A Barrett; Yoshihide Kanaoka; Eri Yoshimoto; Denise Garofalo; Haley Cirka; Chunli Feng; Joshua A Boyce
Journal:  J Immunol       Date:  2017-12-27       Impact factor: 5.422

Review 4.  Nasal potential difference to detect Na+ channel dysfunction in acute lung injury.

Authors:  R Mac Sweeney; H Fischer; D F McAuley
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-11-26       Impact factor: 5.464

5.  Resolution of pulmonary edema. Thirty years of progress.

Authors:  Michael A Matthay
Journal:  Am J Respir Crit Care Med       Date:  2014-06-01       Impact factor: 21.405

6.  Changes in ion transport in inflammatory disease.

Authors:  Michael Eisenhut
Journal:  J Inflamm (Lond)       Date:  2006-03-29       Impact factor: 4.981

Review 7.  Bench-to-bedside review: the role of the alveolar epithelium in the resolution of pulmonary edema in acute lung injury.

Authors:  Rachel L Zemans; Michael A Matthay
Journal:  Crit Care       Date:  2004-06-30       Impact factor: 9.097

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.